Home › Type 2 Diabetes › Texas › Austin
Type 2 Diabetes clinical trials in Austin, TX
11 studies for Type 2 Diabetes are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- IMA Clinical Research Austin, Austin
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RecruitingPhase 3
- Texas Diabetes and Endocrinology - Central Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Austin
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Pinnacle Clinical Research - Austin, Austin
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
RecruitingPhase 2
- IMA Clinical Research, Austin
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Velocity Clinical Research, Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Elligo Clinical Research Center, Austin
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecruitingPhase 3
- Pinnacle Clinical Research, Austin
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Recruiting
- Texas Diabetes & Endocrinology, Austin
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Recruiting
- Texas Diabetes and Endocrinology, Austin
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
RecruitingPhase 2
- Elligo Health Research, Inc., Austin
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX36 studies
- Houston, TX30 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Columbus, OH18 studies
- Dallas, TX18 studies
- Atlanta, GA17 studies
- Las Vegas, NV17 studies
- New York City, NY16 studies
- Birmingham, AL16 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)21 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer19 studies
- Heart Failure18 studies
- Overweight18 studies
- Breast Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer16 studies
- Depression15 studies
- Prostate Cancer15 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.